Mural Oncology (MURA) Earnings Date & Reports

Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

MURA is expected to report earnings to rise 9.09% to -203 cents per share on April 01

Mural Oncology MURA Stock Earnings Reports

Q4'24

Est.

$-2.04

Q3'24

Beat

by $0.10

Q2'24

Beat

by $0.09

Q1'24

Beat

by $0.82

The last earnings report on November 13 showed earnings per share of -187 cents, beating the estimate of -197 cents. With 46.89K shares outstanding, the current market capitalization sits at 62.78M.

View a ticker or compare two or three

Compare

MURA